Arthur Y. Kim

12.0k citations
121 papers · 4.9k · 1 hit paper · h-index 38

Impact in

  • Hepatology top 0.2%
    • Hepatitis C virus research
  • Virology top 1%
    • HIV Research and Treatment

Papers in

    • Hepatitis C virus research 99
    • Hepatitis B Virus Studies 50
    • Liver Disease Diagnosis and Treatment 42
    • HIV, Drug Use, Sexual Risk 17

Arthur Y. Kim

116 papers receiving 4.9k citations

Arthur Y. Kim's Hit Papers

Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System 2022 · 107 citations
1070+1+2Years since publication255075100

Peers

Arthur Y. Kim
Comparison fields: 5 of 137
  • Hepatology 3.3k
  • Virology 658
  • Epidemiology 2.7k
  • Infectious Diseases 1.2k
  • Immunology 1.1k
Replace David Wong with:
David Wong Canada
Margaret James Koziel United States
Markus Cornberg Germany
Marion G. Peters United States
Massimo Puoti Italy
Robert Flisiak Poland
Andrzej Horban Poland
Sandro Vento Italy
Robert H. Hyland United States
Gail Matthews Australia
Arthur Y. Kim relative to David Wong Canada David Wong's profile →
Citations per field
00.5×1.5×2.2×
David Wong · 1×
Citations per year

Countries citing papers authored by Arthur Y. Kim

Since Specialization
Citations

This map shows the geographic impact of Arthur Y. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Y. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Y. Kim more than expected).

Fields of papers citing papers by Arthur Y. Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur Y. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Y. Kim. The network helps show where Arthur Y. Kim may publish in the future.

Co-authors

The 25 scholars most cited alongside Arthur Y. Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arthur Y. Kim Line = papers co-authored together Arthur Y. Kim links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2004241
2 2004231
3 2015182
4 2012180
5 2009172
6 2007162
7 2002162
8 2005159
9 2020149
10 2021146
11 2020136
12 2009136
13 2010111
14
Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System
Hit paper breakdown →
2022107
15 2020105
16 2014103
17 2017102
18 201896
19 201693
20 200592

About Arthur Y. Kim

Arthur Y. Kim is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Immunology and Virology, having authored 121 papers that have together received 4.9k indexed citations. Recurring topics across this work include Hepatitis C virus research (99 papers), Hepatitis B Virus Studies (50 papers), Liver Disease Diagnosis and Treatment (42 papers), HIV, Drug Use, Sexual Risk (17 papers), Immune Cell Function and Interaction (14 papers), HIV Research and Treatment (14 papers), T-cell and B-cell Immunology (10 papers) and COVID-19 Clinical Research Studies (10 papers). The work is most often cited by research in Hepatology (3.3k citations), Virology (658 citations), Epidemiology (2.7k citations), Infectious Diseases (1.2k citations) and Immunology (1.1k citations). Arthur Y. Kim has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Raymond T. Chung, Georg M. Lauer, Todd M. Allen, Jörg Timm, Julian Schulze zur Wiesch, Bruce D. Walker, Paul Klenerman, Kei Ouchi, Michaela Lucas and Lia Laura Lewis‐Ximenez. Their work appears in journals such as Clinical Infectious Diseases, Journal of Virology, The Journal of Infectious Diseases, Hepatology and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact